Evidence map›Paper›PMID 40914159›Full record

ArticleCell2025

IL-25-induced memory type 2 innate lymphoid cells enforce mucosal immunity.

Victor S Cortez, Sara Viragova, Satoshi Koga, Meizi Liu, Claire E O'Leary, Roberto R Ricardo-Gonzalez, Andrew W Schroeder, Nathan Kochhar, Dedeepya Vaka, Dario Boffelli and 4 more

Abstract read
In one paragraph

Article in Cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Group 2 innate lymphoid cells: Where are we 15 years out?The Journal of allergy and clinical immunology · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. ILC2s and their immune checkpoints in the antitumor response.Journal for immunotherapy of cancer · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Victor S CortezDepartment of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Sara ViragovaDepartment of Orofacial Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Satoshi KogaDepartment of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Meizi LiuDepartments of Medicine, Molecular Microbiology, Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Claire E O'LearyDepartment of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Roberto R Ricardo-GonzalezDepartments of Dermatology and Microbiology & Immunology, University of California, San Francisco, San Francisco, CA 94143, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Andrew W SchroederDepartment of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; UCSF Genomics CoLab, University of California, San Francisco, San Francisco, CA 94143, USA.
Nathan KochharUCSF Genomics CoLab, University of California, San Francisco, San Francisco, CA 94143, USA.
Dedeepya VakaDepartment of Pediatrics, Cedars-Sinai Guerin Children's, Los Angeles, CA 90048, USA.
Dario BoffelliDepartment of Pediatrics, Cedars-Sinai Guerin Children's, Los Angeles, CA 90048, USA.
Ophir D KleinDepartment of Orofacial Sciences, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Pediatrics, Cedars-Sinai Guerin Children's, Los Angeles, CA 90048, USA.
Michael S DiamondDepartments of Medicine, Molecular Microbiology, Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Hong-Erh LiangDepartment of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Richard M LocksleyDepartment of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: richard.locksley@ucsf.edu.

Funding

Role of miRNAs in Th2-Driven inflammation in AsthmaP01HL107202 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOCKSLEY, RICHARD M · 2012 to 2023
$23.3M
Parasite immunity orchestrated by type 2 immune cellsR01AI026918 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOCKSLEY, RICHARD M · 1988 to 2022
$3.8M
Modulation of the biliary immune niche by the microbiome - Administrative supplementK22AI166029 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI O'LEARY, CLAIRE E · 2023 to 2025
$333k
NHLBI NIH HHS P01 HL107202NIAID NIH HHS K22 AI166029NIAID NIH HHS R01 AI026918
6 · The paper itself

Abstract

Adaptation of intestinal helminths to vertebrates involved the evolution of strategies to attenuate host tissue damage to support parasite reproduction and dissemination of offspring to the environment. Helminths initiate the IL-25-mediated tuft cell-type 2 innate lymphoid cell (ILC2) circuit that enhances barrier protection of the host, although viable parasites can target and limit this pathway. We used IL-25 alone to create small intestinal adaptation, marked by anatomic and immunologic changes that persisted months after induction. Adaptation was associated with heightened resistance to barrier pathogens, including in the lung, and was enforced by transcriptionally and epigenetically modified effector-memory ILC2s distinct from those described by innate "training"; epithelial stem cells remained unaltered. Despite requiring IL-25 for induction, effector-memory ILC2s maintained an activated state in the absence of multiple alarmins and supported mucosal resilience while avoiding adverse sensitization to chronic inflammation, revealing a pathway for deploying innate immune cells to coordinate a distributed mucosal defense.

Indexed as

Immunity, InnateImmunity, MucosalImmunologic MemoryInterleukinsLymphocytesAnimalsFemaleIntestinal MucosaLungMiceMice, Inbred C57BLNippostrongylusInterleukinsMydgf protein, mousealarminsepigeneticsepithelial stem cellshelminth infectionIL-25ILC2sinnate memorysmall intestinestissue adaptation

Identifiers

PMID40914159
PMCPMC13056343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.